Price $167.63 |
Market Cap
453.62B
|
Sector Health Care |
Div. Growth
5.60%
|
|
P/E
25.6
|
P/B
6.41
|
P/S
4.92
|
Dividend %
2.50%
|
|
P/CF
-
|
P/FCF
39.5
|
Op. Cash Flow
26.02M
|
FCF
4.3
|
|
Op. Margin
21.40%
|
Net Margin
19.60%
|
ROE
26.60%
|
ROI
14.60%
|
|
ROA
10.20%
|
EPS Growth
4.70%
|
Current Ratio
1.2
|
Debt/Equity
51.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Genesis Healthcare Inc (GENN) | $0.19 | - | - | 29.3M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.56 | - | - | 68.5M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $62.46 | - | 3.50% | 138.77B | Strong Buy |
| Cannabis Sativa Inc (CBDS) | $0.20 | - | - | 6M | Strong Buy |
| Castlight Health Inc (CSLT) | $2.04 | - | - | 251.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
